Vijaya Kumar Pidugu, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 37, Room 4060
- Bethesda, MD 20892
Dr. Vijaya Kumar Pidugu has expertise in dissecting molecular signaling mechanisms of cancer response, acquired resistance to biological therapeutics, characterizing preclinical candidates, and molecular target discovery using a variety of cell-based and animal models.
For his Ph.D., Dr. Pidugu studied the oncogenic role of IFIT1 and IFIT3 in oral squamous cell carcinoma metastasis and drug resistance.
As a postdoctoral fellow in Dr. Ji Luo’s lab, he is investigating Kras-driven lung adenocarcinoma progression and drug resistance mechanisms in 3D-lung organoid models by targeting mutant Kras in mouse alveolar epithelial type 2 cells (AEC-2)-derived lung organoids by combinatorial drug screening.
Areas of Expertise
1. Cancer biology, 2. Molecular toxicology, 3. 3D-organoid models